The ethnomedicinal uses of Magnoliaceae from the southeastern United States as leads in drug discovery

Pharmaceutical Biology

Volumn 39, Issue SUPPL., 2001, Pages 63-69

  Schühly, Wolfgang ^a   Khan, Ikhlas ^a   Fischer, Nikolaus H ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Ethnobotany; Ethnomedicine; Lignans; Magnolia; Sesquiterpene lactones

Indexed keywords

COSTUNOLIDE; GLYCOSIDE; HONOKIOL; LIGNAN DERIVATIVE; MAGNOLIDIN; MAGNOLOL; METHYLHONOKIOL; PARTHENOLIDE; SESQUITERPENE LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG RESEARCH; ETHNOPHARMACOLOGY; HERBAL MEDICINE; MAGNOLIACEAE; MEDICINAL PLANT; SOUTH AMERICA;

MAGNOLIA; MAGNOLIACEAE;

EID: 0035727657     PISSN: 13880209     EISSN: None     Source Type: Journal    
DOI: 10.1076/phbi.39.7.63.5874     Document Type: Article

References (67)

1. Essential oils in Ledum L.: Antifungal properties
2. Inhibition of the transcription factor NF-κB by sesquiterpene lactones from Podachaenium eminens
3. Studies on the constituents of Acanthopanax koreanum
4. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L.
5. Intraspecific variability of feverfew: Correlations between parthenolide, morphological traits and seed origin
6. Melampolides from Magnolia grandiflora
7. Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L.
8. Isolation and characterization of peroxycostunolide (verlotorin) and peroxyparthenolide from Magnolia grandiflora. Carbon-13 nuclear magnetic resonance spectroscopy of costunolide and related compounds
9. Peroxycostunolide and peroxyparthenolide: Two cytotoxic germacranolide hydroperoxides from Magnolia grandi-flora. Structural revision of verlotorin and artemorin
10. Phenolic constituents of Magnolia grandiflora L. seeds
11. Sesquiterpenoid lactones
12. Antitumor agents. 121. The cytotoxicity of helenalin, its mono and difunctional esters, and related sesquiterpene lactones in murine and human tumor cells
13. Anti-inflammatory activity of sesquiterpene lactones and related compounds
14. Mode of action of sesquiterpene lactones as anti-inflammatory agents
15. The anti-inflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the lκB kinase complex
16. Feverfew: A review of its history, its biological and medicinal properties, and the status of commercial preparations of the herb
17. Powerful medicinal plants in traditional Iroquois culture
18. Magnolol from Magnolia officinalis inhibits 11β-hydroxysteroid dehydrogenase without increases of corticosterone and thymocyte apoptosis in mice
19. Intravenous pretreatment with magnolol protects myocardium against stunning
20. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases
21. Phytotoxic and antimicrobial properties of cyclocolorenone from Magnolia grandiflora L.
22. Comparative detoxification of plant (Magnolia virginiana) allelochemicals by generalist and specialist saturniid silkmoths
23. Phenylpropenoid phenolics in sweetbay magnolia as chemical determinants of host use in saturniid silkmoths (Callosamia)
24. Cytotoxic components from stem bark of Magnolia obovata
25. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis
26. Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis
27. Novel antitumor agents from higher plants
28. Natural product models as allelochemicals. 1. Potential allelopathic activity of several sesuiterpene lactone models
29. Variations in the sweet bay magnolias
30. Sesquiterpenoids from the liverworts Bazzania trilobata and Porella canariensis
31. Bioactive neolignans from the leaves of Magnolia virginiana
32. Magnolia virginiana neolignan compounds as chemical barriers to swallowtail butterfly host use
33. Glycosides of Magnolia grandiflora. I: Isolation of three crystalline glycosides
34. Constituents of Magnolia grandiflora. I: Mono-O-methylhonokiol
35. Glycosides of Magnolia. II. Structural elucidation of magnolidin
36. Glycosides of Magnolia. III. Structural elucidation of magnolenin C
37. Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion
38. Biologically active lignans and neolignans from Magnolia species
39. Dibenzocyclooctadiene-type lignans from Magnolia pyramidata
40. Sesquiterpenes from southern Magnolia Virginiana
41. Catawba medicines and curative practices
42. A list of plant curatives obtained from the Houma Indians of Louisiana
43. Rappahannock herbals, folk-lore and science of cures
44. Floral odors and quantitative taxonomy of Magnolia and Liriodendron
45. Fungicidal activity of natural and synthetic sesquiterpene lactone analogs
46. Tumor inhibitory agent from Magnolia grandiflora (Magnoliaceae) I: Parthenolide